CASTRATION RESISTANT METASTATIC PROSTATE CANCER

Clinical trials for CASTRATION RESISTANT METASTATIC PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new CASTRATION RESISTANT METASTATIC PROSTATE CANCER trials appear

Sign up with your email to follow new studies for CASTRATION RESISTANT METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

New combo therapy shows promise for tough prostate cancer

Disease control Completed

This study tested the immunotherapy drug nivolumab (Opdivo) combined with one of three other drugs (rucaparib, docetaxel, or enzalutamide) in 292 men with advanced prostate cancer that had spread and stopped responding to hormone therapy. The goal was to see if these combinations…

Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER

Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

CASTRATION RESISTANT METASTATIC PROSTATE CANCER

Get alerted when new CASTRATION RESISTANT METASTATIC PROSTATE CANCER trials appear

New combo therapy shows promise for tough prostate cancer